{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:49:00Z","timestamp":1778942940783,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81201743"],"award-info":[{"award-number":["81201743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["1908085QA27"],"award-info":[{"award-number":["1908085QA27"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["KJ2021A0295"],"award-info":[{"award-number":["KJ2021A0295"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Disabled homolog 2 interacting protein (DAB2IP) plays a tumor-suppressive role in several types of human cancers. However, the molecular status and function of the DAB2IP gene in esophageal squamous cell carcinoma (ESCC) patients who received definitive chemoradiotherapy is rarely reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We examined the expression dynamics of DAB2IP by immunohistochemistry (IHC) in 140 ESCC patients treated with definitive chemoradiotherapy. A series of in vivo and in vitro experiments were performed to elucidate the effect of DAB2IP on the chemoradiotherapy (CRT) response and its underlying mechanisms in ESCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Decreased expression of DAB2IP in ESCCs correlated positively with ESCC resistance to CRT and was a strong and independent predictor for short disease-specific survival (DSS) of ESCC patients. Furthermore, the therapeutic sensitivity of CRT was substantially increased by ectopic overexpression of DAB2IP in ESCC cells. In addition, knockdown of DAB2IP dramatically enhanced resistance to CRT in ESCC. Finally, we demonstrated that DAB2IP regulates ESCC cell radiosensitivity through enhancing ionizing radiation (IR)-induced activation of the ASK1-JNK signaling pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data highlight the molecular etiology and clinical significance of DAB2IP in ESCC, which may represent a new therapeutic strategy to improve therapy and survival for ESCC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12935-022-02535-9","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T12:03:00Z","timestamp":1646481780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-7331","authenticated-orcid":false,"given":"Zhuting","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YeYe","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaguang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangcun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"issue":"6","key":"2535_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2535_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jmri.25934","volume":"48","author":"H Zheng","year":"2018","unstructured":"Zheng H, Ren W, Pan X, Zhang Q, Liu B, Liu S, He J, Zhou Z. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: a pilot study. J Magn Reson Imaging. 2018;48(2):349\u201358.","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"2535_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1517\/14656566.2013.801454","volume":"14","author":"M Nakajima","year":"2013","unstructured":"Nakajima M, Kato H. Treatment options for esophageal squamous cell carcinoma. Expert Opin Pharmacother. 2013;14(10):1345\u201354.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2535_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1006\/geno.2002.6739","volume":"79","author":"H Chen","year":"2002","unstructured":"Chen H, Pong RC, Wang Z, Hsieh JT. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics. 2002;79(4):573\u201381.","journal-title":"Genomics"},{"issue":"15","key":"2535_CR5","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1074\/jbc.M110568200","volume":"277","author":"Z Wang","year":"2002","unstructured":"Wang Z, Tseng CP, Pong RC, Chen H, McConnell JD, Navone N, Hsieh JT. The mechanism of growth-inhibitory effect of DOC-2\/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2\/DAB2. J Biol Chem. 2002;277(15):12622\u201331.","journal-title":"J Biol Chem"},{"issue":"7","key":"2535_CR6","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1158\/0008-5472.CAN-09-2919","volume":"70","author":"Z Kong","year":"2010","unstructured":"Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, Saha D. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Can Res. 2010;70(7):2829\u201339.","journal-title":"Can Res"},{"issue":"1","key":"2535_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijc.20531","volume":"113","author":"M Yano","year":"2005","unstructured":"Yano M, Toyooka S, Tsukuda K, Dote H, Ouchida M, Hanabata T, Aoe M, Date H, Gazdar AF, Shimizu N. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer. 2005;113(1):59\u201366.","journal-title":"Int J Cancer"},{"issue":"4","key":"2535_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jhep.2006.11.012","volume":"46","author":"GH Qiu","year":"2007","unstructured":"Qiu GH, Xie H, Wheelhouse N, Harrison D, Chen GG, Salto-Tellez M, Lai P, Ross JA, Hooi SC. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol. 2007;46(4):655\u201363.","journal-title":"J Hepatol"},{"issue":"35","key":"2535_CR9","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1038\/onc.2016.4","volume":"35","author":"J Zhou","year":"2016","unstructured":"Zhou J, Luo J, Wu K, Yun EJ, Kapur P, Pong RC, Du Y, Wang B, Authement C, Hernandez E, et al. Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies. Oncogene. 2016;35(35):4663\u201374.","journal-title":"Oncogene"},{"issue":"17","key":"2535_CR10","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-15-0088","volume":"75","author":"W Ji","year":"2015","unstructured":"Ji W, Li Y, He Y, Yin M, Zhou HJ, Boggon TJ, Zhang H, Min W. AIP1 expression in tumor niche suppresses tumor progression and metastasis. Can Res. 2015;75(17):3492\u2013504.","journal-title":"Can Res"},{"issue":"12","key":"2535_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1593\/neo.121310","volume":"14","author":"L Yu","year":"2012","unstructured":"Yu L, Tumati V, Tseng SF, Hsu FM, Kim DN, Hong D, Hsieh JT, Jacobs C, Kapur P, Saha D. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia. 2012;14(12):1203\u201312.","journal-title":"Neoplasia"},{"issue":"4","key":"2535_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/09553002.2016.1257831","volume":"93","author":"R Chang","year":"2017","unstructured":"Chang R, He H, Mao G, Kong Z. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells. Int J Radiat Biol. 2017;93(4):386\u201393.","journal-title":"Int J Radiat Biol"},{"issue":"14","key":"2535_CR13","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1158\/1078-0432.CCR-18-3004","volume":"25","author":"EJ Yun","year":"2019","unstructured":"Yun EJ, Lin CJ, Dang A, Hernandez E, Guo J, Chen WM, Allison J, Kim N, Kapur P, Brugarolas J, et al. Downregulation of human DAB2IP gene expression in renal cell carcinoma results in resistance to ionizing radiation. Clin Cancer Res. 2019;25(14):4542\u201351.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2535_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijrobp.2014.03.035","volume":"89","author":"C Jacobs","year":"2014","unstructured":"Jacobs C, Tumati V, Kapur P, Yan J, Hong D, Bhuiyan M, Xie XJ, Pistenmaa D, Yu L, Hsieh JT, et al. DOC-2\/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2014;89(4):729\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2535_CR15","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.cellsig.2015.09.014","volume":"27","author":"K Wu","year":"2015","unstructured":"Wu K, Wang B, Chen Y, Zhou J, Huang J, Hui K, Zeng J, Zhu J, Zhang K, Li L, et al. DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3\/Twist1\/P-glycoprotein signaling. Cell Signal. 2015;27(12):2515\u201323.","journal-title":"Cell Signal"},{"key":"2535_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2147\/OTT.S289722","volume":"14","author":"G Wang","year":"2021","unstructured":"Wang G, Wang X, Han M, Wang X. Loss of DAB2IP contributes to cell proliferation and cisplatin resistance in gastric cancer. Onco Targets Ther. 2021;14:979\u201388.","journal-title":"Onco Targets Ther"},{"key":"2535_CR17","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.2147\/OTT.S178131","volume":"11","author":"D Sun","year":"2018","unstructured":"Sun D, Chen C, Hu W, Zhong C, Fan L, Song X, Gai Z. Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer. Onco Targets Ther. 2018;11:7699\u2013707.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"2535_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/gut.2010.231993","volume":"60","author":"MY Cai","year":"2011","unstructured":"Cai MY, Tong ZT, Zheng F, Liao YJ, Wang Y, Rao HL, Chen YC, Wu QL, Liu YH, Guan XY, et al. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut. 2011;60(7):967\u201376.","journal-title":"Gut"},{"issue":"5","key":"2535_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/onc.2011.254","volume":"31","author":"ZT Tong","year":"2012","unstructured":"Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1\/HDAC2 and Snail to inhibit E-cadherin. Oncogene. 2012;31(5):583\u201394.","journal-title":"Oncogene"},{"issue":"1","key":"2535_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijc.25031","volume":"127","author":"LR He","year":"2010","unstructured":"He LR, Liu MZ, Li BK, Jia WH, Zhang Y, Liao YJ, Chen YC, Zhang LJ, Guan XY, Zeng YX, et al. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Int J Cancer. 2010;127(1):138\u201347.","journal-title":"Int J Cancer"},{"issue":"11","key":"2535_CR21","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/ijc.27930","volume":"132","author":"JX Zhang","year":"2013","unstructured":"Zhang JX, Tong ZT, Yang L, Wang F, Chai HP, Zhang F, Xie MR, Zhang AL, Wu LM, Hong H, et al. PITX2: a promising predictive biomarker of patients\u2019 prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Int J Cancer. 2013;132(11):2567\u201377.","journal-title":"Int J Cancer"},{"issue":"21","key":"2535_CR22","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2535_CR23","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/bjc.2013.81","volume":"108","author":"ZT Tong","year":"2013","unstructured":"Tong ZT, Wei JH, Zhang JX, Liang CZ, Liao B, Lu J, Fan S, Chen ZH, Zhang F, Ma HH, et al. AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1. Br J Cancer. 2013;108(7):1470\u20139.","journal-title":"Br J Cancer"},{"issue":"3","key":"2535_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nm.2100","volume":"16","author":"J Min","year":"2010","unstructured":"Min J, Zaslavsky A, Fedele G, McLaughlin SK, Reczek EE, De Raedt T, Guney I, Strochlic DE, Macconaill LE, Beroukhim R, et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med. 2010;16(3):286\u201394.","journal-title":"Nat Med"},{"issue":"5","key":"2535_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ijrobp.2009.10.037","volume":"76","author":"B Hofstetter","year":"2010","unstructured":"Hofstetter B, Niemierko A, Forrer C, Benhattar J, Albertini V, Pruschy M, Bosman FT, Catapano CV, Ciernik IF. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. Int J Radiat Oncol Biol Phys. 2010;76(5):1512\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2535_CR26","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.21037\/jtd.2017.03.39","volume":"9","author":"CL Donohoe","year":"2017","unstructured":"Donohoe CL, Phillips AW. Cancer of the esophagus and esophagogastric junction: an 8(th) edition staging primer. J Thorac Dis. 2017;9(3):E282\u20134.","journal-title":"J Thorac Dis"},{"issue":"4","key":"2535_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semradonc.2010.05.004","volume":"20","author":"A Sak","year":"2010","unstructured":"Sak A, Stuschke M. Use of gammaH2AX and other biomarkers of double-strand breaks during radiotherapy. Semin Radiat Oncol. 2010;20(4):223\u201331.","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"2535_CR28","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1083\/jcb.151.7.1381","volume":"151","author":"LB Schultz","year":"2000","unstructured":"Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol. 2000;151(7):1381\u201390.","journal-title":"J Cell Biol"},{"issue":"45","key":"2535_CR29","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","volume":"276","author":"S Burma","year":"2001","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276(45):42462\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"2535_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/09553000802662595","volume":"85","author":"RE Meyn","year":"2009","unstructured":"Meyn RE, Milas L, Ang KK. The role of apoptosis in radiation oncology. Int J Radiat Biol. 2009;85(2):107\u201315.","journal-title":"Int J Radiat Biol"},{"issue":"47","key":"2535_CR31","doi-asserted-by":"publisher","first-page":"19878","DOI":"10.1073\/pnas.0908458106","volume":"106","author":"D Xie","year":"2009","unstructured":"Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, Hsieh JT. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci USA. 2009;106(47):19878\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"43","key":"2535_CR32","doi-asserted-by":"publisher","first-page":"44955","DOI":"10.1074\/jbc.M407617200","volume":"279","author":"H Zhang","year":"2004","unstructured":"Zhang H, Zhang R, Luo Y, D\u2019Alessio A, Pober JS, Min W. AIP1\/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. J Biol Chem. 2004;279(43):44955\u201365.","journal-title":"J Biol Chem"},{"issue":"15","key":"2535_CR33","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1073\/pnas.96.15.8511","volume":"96","author":"L Zhang","year":"1999","unstructured":"Zhang L, Chen J, Fu H. Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA. 1999;96(15):8511\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2535_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/onc.2009.382","volume":"29","author":"LM Cockrell","year":"2010","unstructured":"Cockrell LM, Puckett MC, Goldman EH, Khuri FR, Fu H. Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome. Oncogene. 2010;29(6):822\u201330.","journal-title":"Oncogene"},{"issue":"7","key":"2535_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1172\/JCI11947","volume":"107","author":"Y Liu","year":"2001","unstructured":"Liu Y, Yin G, Surapisitchat J, Berk BC, Min W. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Investig. 2001;107(7):917\u201323.","journal-title":"J Clin Investig"},{"issue":"11","key":"2535_CR36","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1074\/jbc.M311129200","volume":"279","author":"EH Goldman","year":"2004","unstructured":"Goldman EH, Chen L, Fu H. Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation. J Biol Chem. 2004;279(11):10442\u20139.","journal-title":"J Biol Chem"},{"issue":"12","key":"2535_CR37","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1172\/JCI200317790","volume":"111","author":"R Zhang","year":"2003","unstructured":"Zhang R, He X, Liu W, Lu M, Hsieh JT, Min W. AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Investig. 2003;111(12):1933\u201343.","journal-title":"J Clin Investig"},{"issue":"5296","key":"2535_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.275.5296.90","volume":"275","author":"H Ichijo","year":"1997","unstructured":"Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways. Science. 1997;275(5296):90\u20134.","journal-title":"Science"},{"issue":"9","key":"2535_CR39","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","volume":"17","author":"M Saitoh","year":"1998","unstructured":"Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17(9):2596\u2013606.","journal-title":"EMBO J"},{"issue":"1","key":"2535_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jbior.2012.09.006","volume":"53","author":"S Shiizaki","year":"2013","unstructured":"Shiizaki S, Naguro I, Ichijo H. Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling. Adv Biol Regul. 2013;53(1):135\u201344.","journal-title":"Adv Biol Regul"},{"issue":"1","key":"2535_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/09553009414550041","volume":"65","author":"PA Riley","year":"1994","unstructured":"Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 1994;65(1):27\u201333.","journal-title":"Int J Radiat Biol"},{"issue":"5 Suppl","key":"2535_CR42","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.2307\/3579809","volume":"150","author":"SS Wallace","year":"1998","unstructured":"Wallace SS. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res. 1998;150(5 Suppl):S60-79.","journal-title":"Radiat Res"},{"issue":"4","key":"2535_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4103\/0973-1482.146073","volume":"10","author":"R Dayal","year":"2014","unstructured":"Dayal R, Singh A, Pandey A, Mishra KP. Reactive oxygen species as mediator of tumor radiosensitivity. J Cancer Res Ther. 2014;10(4):811\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"2535_CR44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCRESAHA.107.168153","volume":"102","author":"W Min","year":"2008","unstructured":"Min W, Lin Y, Tang S, Yu L, Zhang H, Wan T, Luhn T, Fu H, Chen H. AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation. Circ Res. 2008;102(7):840\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"2535_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cdd.2016.134","volume":"24","author":"A Bellazzo","year":"2017","unstructured":"Bellazzo A, Di Minin G, Collavin L. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer. Cell Death Differ. 2017;24(1):15\u201325.","journal-title":"Cell Death Differ"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-022-02535-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02535-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T09:07:54Z","timestamp":1666516074000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-022-02535-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2535"],"URL":"https:\/\/doi.org\/10.1186\/s12935-022-02535-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients authorized the use of their specimens by written informed consent. This study was approved by the Institute Research Medical Ethics Committee of Anhui Medical University (Hefei, China). This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors involved in the study had given their consent for submitting this article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}